The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic.
Bieghs L, Lub S, Fostier K, Maes K, Van Valckenborgh E, Menu E, Johnsen HE, Overgaard MT, Larsson O, Axelson M, Nyegaard M, Schots R, Jernberg-Wiklund H, Vanderkerken K, De Bruyne E.
Bieghs L, et al. Among authors: maes k.
Oncotarget. 2014 Nov 30;5(22):11193-208. doi: 10.18632/oncotarget.1933.
Oncotarget. 2014.
PMID: 25008202
Free PMC article.